Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-25
2007-12-25
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S250000
Reexamination Certificate
active
10491680
ABSTRACT:
Pyrimidine derivatives of the formula (I) and physiologically acceptable salts thereof, in which R1, R2, R3, R4, W, X, Y and Z are as defined in claim1,exhibit phosphodiesterase V inhibition and can be employed for the treatment of diseases of the cardiovascular system and for the treatment and/or therapy of potency disorders
REFERENCES:
patent: 3037980 (1962-06-01), Hitchings et al.
patent: 4007187 (1977-02-01), Fauran et al.
patent: 0 046 677 (1982-03-01), None
patent: 0 514 540 (1992-11-01), None
patent: 0 728 759 (1996-08-01), None
patent: 98 17668 (1998-04-01), None
patent: 99 28325 (1999-06-01), None
patent: 99 55708 (1999-11-01), None
patent: 99 62518 (1999-12-01), None
patent: WO 99 62518 (1999-12-01), None
patent: 01 18004 (2001-03-01), None
patent: 01 21620 (2001-03-01), None
patent: 01 39777 (2001-06-01), None
patent: WO 01/39777 (2001-06-01), None
patent: 02 057267 (2002-07-01), None
West, Anthony R., Solid State Chemistry and Its Applications, Wiley, New York (1988).
Meade, et al., Anxiolytic Activity of Analogues of 4-benzylamino-2-methyl-7H-pyrrolo[2,3-d]pyrimidines, Eur. J. Med. Chem., pp. 363-374, vol. 33 (1998).
Campbell, et al., Selective A1-adenosine Receptor Antagonists Identified Using YeastSaccharomyces cerevisiaeFunctional Assays, Bioorganic & Medicinal Chemistry Letters, 9, 2413-2418 (1999).
Chemical Abstracts No. 48031, vol. 80, No. 9 (Mar. 4, 1974).
Chemical Abstracts No. 82224, vol. 82, No. 13 (Mar. 31, 1975).
Chemical Abstracts No. 126924, vol. 76, No. 21 (May 22, 1972).
Chemical Abstracts, vol. 63, No. 11 (1965).
Chemical Abstracts No. 97174, vol. 111, No. 11 (Sep. 11, 1989).
Chemical Abstracts No. 112617, vol. 123, No. 9 (Aug. 28, 1995).
Chemical Abstracts No. 79191, vol. 83, No. 9 (Sep. 1, 1975).
R. Campbell, et al., “Selective A1-Adenosine Receptor . . . Functional Assays”,Bioorganic&Medicinal Chemistry Letters, Bd. 9, Nr. 16 (Aug. 16, 1999).
E. Meade, et al., “Anxiolytic Activity . . . pyrimidines”,European Journal of Medicinal Chemistry, Bd. 33, Nr. 5, (Jun. 1, 1998).
West, et al., “2-Alkyl(aryl) . . . pyrimidines”,J. Org. Chem, Bd. 26 (1961).
Lockhart et al., “Synthesis of Subtituted furo . . . ”,J. Heterocyclic Chem, Bd. 33, Nr. 3 (1996).
J-P Marquet et al., “Furannes et Pyrroles . . . 4-Substitut”,Bulletin de la Societe Chimique de France, Nr. 12 (1969).
Baumgarth Manfred
Beier Norbert
Christadler Maria
Eggenweiler Hans-Micahel
Schelling Pierre
Leeser Erich A.
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Wilson James O.
LandOfFree
Pyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3893819